Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency

Calcified Tissue International

Volumn 62, Issue 1, 1998, Pages 40-46

  Kotzmann, H ^a   Riedl, M ^a   Bernecker, P ^a   Clodi, M ^a   Kainberger, F ^a   Kaider, A ^a   Woloszczuk, W ^a   Luger, A ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bone metabolism; Bone mineral density; GH substitution therapy; Growth hormone deficiency; Osteoporosis

Indexed keywords

COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; DESMOPRESSIN; HYDROCORTISONE; LEVOTHYROXINE; OSTEOCALCIN; PREDNISONE; PROCOLLAGEN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTHRALGIA; ARTICLE; BONE DENSITY; BONE METABOLISM; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EDEMA; ENDOCRINE DISEASE; FEMALE; FEMUR NECK; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; LUMBAR SPINE; MALE; MYALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALKALINE PHOSPHATASE; AMINO ACIDS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; COLLAGEN; CREATININE; DOUBLE-BLIND METHOD; FEMALE; FEMUR NECK; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PROCOLLAGEN; TIME FACTORS; VITAMIN D;

EID: 0031985833     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900392     Document Type: Article

References (31)

1. Aloia JF, Zanzi I, Ellis K, Jowsey J, Roginsky M, Wallach ST, Cohn SH (1976) Effects of growth hormone in osteoporosis. J Clin Endocrinol Metab 43:992-998
2. Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH (1985) Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 34:124-129
3. Isgaard J, Nilsson A, Lindahl A, Jansson JO. Isakson OG (1986) Effects of local administration of GH and IGF-I on longitudinal bone growth in rats. Am J Physiol 250:E367-372
4. Schlechter NL, Russel SM, Spencer EM, Nicoll CS (1986) Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 83: 7931-7934
5. Schoenle E. Zapf J. Humbel RE, Froesch ER (1982) Insulinlike growth factor I simulates growth in hypophysektomized rats. Nature 296:252-253
6. Hill PA, Reynolds JJ, Meikle MC (1995) Osteoblasts mediate insulin-like growth factor I and II stimulation of osteoclast formation and function. Endocrinology 136:124-131
7. Kotzmann H, Bernecker P. Hübsch P, Pietschmann P. Woloszczuk W, Svoboda T, Geyer G, Luger A (1993) Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res 8:459-465
8. Diamond T. Nery L, Posen L (1989) Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Int Med 111:567-573
9. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ (1980) Bone mineral status in growth hormone deficiency. J Pediatr 96:393-396
10. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M (1992) Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 74:118-123
11. Wüster CHR, Slenczka E, Ziegler R (1991) Erhöhte Prävalenz von Osteoporose und Arteriosklerose bei konventionell substituierter Hypophysenvorderlappeninsuffmenz: Bedarf einer zusätzlichen Wachstumshormonsubstitution? Klin Wochenschr 69:769-773
12. Holmes SJ, Economou G, Whitehousc RW, Adams JE, Shalet SM (1994) Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 78:669-674
13. Rosen T, Hansson T, Granhed H. Szucs J. Bengtsson BA (1993) Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol 129:201-206
14. Degerblad M, Bengtsson BA, Mramnert M. Johnell O, Manhem P, Rosen T. Thoren M (1995) Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy. Eur J Endocrinol 133:180-188
15. Holmes SJ, Whitehouse RW, Economous G, O'Halloran DJ, Adams JE, Shalet SM (1995) Effect of growth hormone replacement on bone mass in adult-onset growth hormone deficiency. Clin Endocrinol 42:3-7
16. Blum WF, Ranke MB, Bierich JR (1986) Isolation and partial characterization of six somatomedin-like peptides from human plasma conn fraction. Acta Endocrinol 111:271-284
17. Bouillon R (1991) Growth hormone and bone. Horm Res 36(suppl 1):49-55
18. Morel G, Chavassieux P, Barenton B, Dubois PM, Meunier PJ, Boivin G (1993) Evidence for a direct effect of growth hormone on osteoblasts. Cell Tissue Res 273:279-286
19. Lobie PE, Garcia Aragon J, Wang BS, Baumbach WR, Waters MJ (1992) Cellular localization of the growth hormone binding protein in the rat. Endocrinology 130:3057-3065
20. Canalis E (1980) Effect of insulin-like growth factor I on DNA and protein synthesis in cultured rat calvaria. J Clin Invest 66:709-719
21. Kassem M, Mosekilde L, Eriksen EF (1994) Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro. Growth Regulation 4:131-135
22. Hill PA, Reynolds JJ, Meikle MC (1995) Osteoblasts mediate insulin-like growth factor I and II stimulation of osteoclast formation and function. Endocrinology 136:124-131
23. Nishiyama K, Sugimoto T, Kaji H, Kanatani M, Kobayashi T, Chihara K (1996) Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. Endocrinology 137:35-41
24. Andreassen TT, Jorgensen PH, Flyvbjerg A, Orskov H, Oxlund H (1995) Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 10:1057-1067
25. Andreassen TT, Meisen F, Oxlund H (1996) The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats. J Bone Miner Res 11:1094-1102
26. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM (1993) Increased bone density after recombinant human growth (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76:1344-1348
27. Binnerts A, Swart GR, Wilson JHP, Hoogerbrugge N. Pols HAP, Birkenhagcr JC, Lamberts SWJ (1992) The effect of growth hormone administration in growth hormone-deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as body composition. Clin Endocrinol 37:79-87
28. Degerblad M, Elgindy N, Hall K. Sjöberg HE, Thoren M (1992) Potent effect of recombinanl growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol 126:387-393
29. Vandeweghe M, Taelman P, Kaufman JM (1993) Short-and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormonedeficient males. Clin Endocrinol 39:409-415
30. Johansson G, Rosen T, Bosaeus I. Hallgren P. Bengtsson BA (1994) The effects of 2 years treatment with recombinant human growth hormone (RHGH) in growth hormone-deficient adults (GHDA). Endocrinol Metab 1 (suppl B):12
31. Rosen T, Johansson G, Hallgren P, Caidahl K, Bosaeus I. Bengtsson BA (1994) Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone-deficient adults. Endocrinol Metab 1:55-66